| 000 | 01493 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250515115736.0 | ||
| 264 | 0 | _c20080529 | |
| 008 | 200805s 0 0 eng d | ||
| 022 | _a1440-1827 | ||
| 024 | 7 |
_a10.1111/j.1440-1827.2008.02222.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNakayama, Masato | |
| 245 | 0 | 0 |
_aPathological evaluation of uterine leiomyomas treated with gonadotropin-releasing hormone agonist (GnRH-a) therapy: role of mast cells and a possible mechanism of GnRH-a resistance in leiomyomas. _h[electronic resource] |
| 260 |
_bPathology international _cMay 2008 |
||
| 300 |
_a268-74 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xtherapeutic use |
| 650 | 0 | 4 | _aCell Count |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGonadotropin-Releasing Hormone _xagonists |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsulin-Like Growth Factor I _xmetabolism |
| 650 | 0 | 4 |
_aLeiomyoma _xdrug therapy |
| 650 | 0 | 4 |
_aLeuprolide _xtherapeutic use |
| 650 | 0 | 4 |
_aMast Cells _xdrug effects |
| 650 | 0 | 4 | _aPremenopause |
| 650 | 0 | 4 |
_aUterine Neoplasms _xdrug therapy |
| 700 | 1 | _aMitsuhashi, Tomoko | |
| 700 | 1 | _aShimizu, Yoshihiko | |
| 700 | 1 | _aIshihara, Osamu | |
| 700 | 1 | _aShimizu, Michio | |
| 773 | 0 |
_tPathology international _gvol. 58 _gno. 5 _gp. 268-74 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1440-1827.2008.02222.x _zAvailable from publisher's website |
| 999 |
_c17927082 _d17927082 |
||